6th International China Pharmaceutical R&D Summit
Venue: Grang Hyatt
|Event Date/Time: Apr 11, 2011||End Date/Time: Apr 13, 2011|
will be sharing their expert opinions and experiences on transformation & innovation in China, clinical challenges, regulatory
updates , NCE discovery efforts, preclinical partnerships, biosimilars development and more!
The 2011 event will feature 3 concurrent conferences â€“ Clinical & Regulatory Summit; Discovery to PreClinical Development & Partnerships; and Biologics & Biosimilars Development, with shared Keynotes and a Plenary Session focusing on Transformation & Innovation in China-the Next Stage in Chinaâ€™s Life Sciences Industry. Participants will be able to choose the conference of their choice or mix-and-match sessions from all 3 conferences, while taking advantage of the shared sessions and networking breaks to meet with other executives and scientists at the event.
With proven attendance from top-level executives from Chinaâ€™s major pharma and
biotech companies, this is THE MEETING PLACE to network and share experiences,
meet potential partners and foster business relationships.
Clinical & Regulatory Summit:
Understand the Regulatory Environment in China
â€¢ Hear from a tuned-in clinical CRO on the changing Chinese regulatory system; a US companyâ€™s insight on conducting global trials in Asiaâ€™s dynamic regulatory environment; and a leading consultantâ€™s strategy to bring
Chinese-originated drugs and biologics to US market.
â€¢ Benefit from these Tried & Proven Clinical Strategies and Case Studies:
â€¢ FIH Study in China: from IND Application to Study Completion
â€¢ Getting Ready for Global Trials in China
â€¢ Conducting Health Economics & Outcomes Research in China
â€¢ Developing Risk Management Plan in Clinical Trials
â€¢ Bridging China Data with Global Data â€“ Global Simultaneous Development
â€¢ Trials & Tribulations of Starting Clinical Trials in a New Geographic Region
Discovery to Preclinical Development & Partnerships:
*Hear the Latest in NCE Development from these Domestic Chinese Companies:
â€¢ Dongyangguang Pharmaceuticals, Ascentage Pharma, IMPACT Therapeutics, Sunwei Therapeutics, Argusina Shanghai, Nanjing Changao Pharmaceutical, Luye Pharma Group and TOT Shanghai
*Get Exciting Partnering Strategies and Updates from:
â€¢ Roche, Simcere Pharmaceuticals, Pfizer, AstraZeneca, Fosun Pharmaceutical ,
Synta Pharmaceuticals, DCB Taiwan, GSK and Eli Lilly